In a move aimed at improving its competitive position in computer-aided detection and enhancing its oncology product portfolio, Siemens Medical Solutions has acquired CADVision Medical Technologies. The 10-year-old R&D company, based in Jerusalem,
In a move aimed at improving its competitive position in computer-aided detection and enhancing its oncology product portfolio, Siemens Medical Solutions has acquired CADVision Medical Technologies. The 10-year-old R&D company, based in Jerusalem, Israel, has developed algorithms that detect and classify breast lesions. Siemens may leverage the technology, which is now undergoing clinical validation, across several applications and multiple modalities.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.